Resonance Health Ltd

Resonance Health Ltd is an Australian MedTech company founded in 2000. The company specializes in innovative imaging technologies and clinical trial services. Resonance Health develops and commercializes non-invasive medical imaging analysis systems, including Core Lab and AI-powered products. Their flagship product, FerriScan, accurately measures liver iron concentration, crucial for managing patients with potentially fatal iron overload conditions. Additionally, Resonance Clinical, the clinical trial division, offers a broad range of services from standalone diagnostic imaging to fully integrated clinical trial research. The company holds regulatory clearances from FDA, CE, TGA and ISO certification for medical devices (13485). Resonance Health operates at the intersection of technology and healthcare, contributing to improved patient care and clinical research.